Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Dare Bioscience Inc (122G)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.278 +0.019    +7.34%
26/04 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US23666P1012 
S/N:  A2DU45
  • Volume: 10,200
  • Bid/Ask: 0.279 / 0.287
  • Day's Range: 0.264 - 0.278
Dare Bioscience 0.278 +0.019 +7.34%

Dare Bioscience Inc Company Profile

 
Get an in-depth profile of Dare Bioscience Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

25

Equity Type

ORD

Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women’s health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older. It is developing Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia or pain during sexual intercourse; and DARE-CIN to treat cervical intraepithelial neoplasia and other human papillomavirus related pathologies. The company is also developing DARE-PDM1 for the treatment of primary dysmenorrhea; DARE-204 and DARE-214, an injectable formulations contraception of etonogestrel designed to provide contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. In addition, it is developing DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein. Daré Bioscience, Inc. is headquartered in San Diego, California.

Contact Information

Address 3655 Nobel Drive Suite 260
San Diego, 92122
United States
Phone 858 926 7655
Fax -

Top Executives

Name Age Since Title
Susan L. Kelley 68 2014 Independent Director
Robin J. Steele 67 2017 Independent Director
Jessica D. Grossman 51 2018 Independent Director
Gregory W. Matz 63 2018 Independent Director
William H. Rastetter 75 2014 Independent Chairman of the Board
Robert S. Langer 74 2019 Member of Scientific Advisory Board
Sabrina Martucci Johnson 57 2015 CEO, President, Principal Financial Officer, Secretary & Director
Cheryl Renee Blanchard 60 2019 Independent Director
Sophia N. Ononye-Onyia 39 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DARE Comments

Write your thoughts about Dare Bioscience Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Vlad Stikhanovskii
Vlad Stikhanovskii Dec 09, 2021 4:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
back to 1.75...
Ma Wa
Ma Wa Dec 09, 2021 4:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1.75 was a good price :D
Jacky Lee
Jacky Lee Dec 06, 2021 11:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No brainer buy!!
Maor Gavriel
Maor Gavriel Oct 27, 2021 2:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When will be the discussion whether ther get the FDA approval?
Joshua Taylor
Joshua Taylor Aug 24, 2021 1:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To $30! 🚀🚀🚀Just waiting on the FDA, theyre slower than molassis unless their dealing with big money and political pressure. With enough bribes, they’ll approve the clinical use of snake oil.
Jacky Lee
Jacky Lee Aug 10, 2021 5:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The first drug is so close to fda approval and commecialization and revenue generation from zero base. Yet the share price has been stagnant for longest time. Whats wrong?
Ahmed Almuqayad
Ahmed Almuqayad Aug 10, 2021 5:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think it will explode maybe today. it's very undervalued stock. it should be 10 usd.
Joshua Taylor
Joshua Taylor Aug 10, 2021 5:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bill Gates recently granted money to Dare Bioscience. 🚀
Feed Seow
Feed Seow Jul 09, 2021 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Abbott will pay good money for Dare
Rambi Zambi
Rambi Zambi Jul 09, 2021 4:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This us one of WSB reditt stock
Rambi Zambi
Rambi Zambi Jul 09, 2021 4:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Abbott will end in buying this co
Ashkan Rahimi
Ashkan Rahimi Jul 08, 2021 10:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
xela is next wallbets stock
NY Brokers Stock Exchange
NY Brokers Stock Exchange Jul 08, 2021 8:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i have no experience in crude oil sorry only in equities is good to buy now Dare but if you want more advises you can ask me
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email